loadpatents
name:-0.03510594367981
name:-0.027985811233521
name:-0.0025479793548584
Hale; Jeffrey J. Patent Filings

Hale; Jeffrey J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hale; Jeffrey J..The latest application filed is for "novel prolylcarboxypeptidase inhibitors".

Company Profile
3.38.32
  • Hale; Jeffrey J. - Westfield NJ US
  • - Westfield NJ US
  • Hale, Jeffrey J - Westfield NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Prolylcarboxypeptidase inhibitors
Grant 9,365,539 - Hale , et al. June 14, 2
2016-06-14
Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
Grant 8,921,555 - Pierce , et al. December 30, 2
2014-12-30
Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
Grant 08921555 -
2014-12-30
Substituted 4-hydroxypyrimidine-5-carboxamides
Grant 8,815,865 - Clements , et al. August 26, 2
2014-08-26
Spiroazaindoles
Grant 8,492,398 - July 23, 2
2013-07-23
Tetrahydrofuropyridones
Grant 8,471,024 - Colandrea , et al. June 25, 2
2013-06-25
Tetrahydrothieno pyridines
Grant 8,445,680 - Debenham , et al. May 21, 2
2013-05-21
Novel Prolylcarboxypeptidase Inhibitors
App 20130040929 - Hale; Jeffrey J. ;   et al.
2013-02-14
Tetrahydro-1H-pyrrolo fused pyridones
Grant 8,372,863 - Clements , et al. February 12, 2
2013-02-12
Substituted 4-hydroxypyrimidine-5-carboxamides
Grant 8,372,857 - Clements , et al. February 12, 2
2013-02-12
Pyrrolidine derived beta 3 adrenergic receptor agonists
Grant 8,354,403 - Edmondson , et al. January 15, 2
2013-01-15
Spiroindalones
Grant 8,309,544 - Fletcher , et al. November 13, 2
2012-11-13
Substituted 4-hydroxypyrimidine-5-carboxamides
Grant 8,278,304 - Clements , et al. October 2, 2
2012-10-02
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists
App 20120157432 - Edmondson; Scott D. ;   et al.
2012-06-21
Substituted 4-hydroxypyrimidine-5-carboxamides
App 20120142694 - Clements; Matthew J. ;   et al.
2012-06-07
Substituted Esters as Cannabinoid-1 Receptor Modulators
App 20120135975 - Colandrea; Vincent J. ;   et al.
2012-05-31
Substituted 4-hydroxypyrimidine-5-carboxamides
App 20120108600 - Clements; Matthew J. ;   et al.
2012-05-03
Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
App 20120095001 - Pierce; Joan M. ;   et al.
2012-04-19
Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
Grant 7,999,107 - Debenham , et al. August 16, 2
2011-08-16
Spiroazaindoles
App 20110152304 - Pierce (nee Fletcher); Joan M. ;   et al.
2011-06-23
Heterocycle-substituted 3-alkyl azetidine derivatives
Grant 7,906,652 - Baker , et al. March 15, 2
2011-03-15
Tetrahydrothieno Pyridines
App 20110009425 - Debenham; John S. ;   et al.
2011-01-13
Tetrahydro-1h-pyrrolo Fused Pyridones
App 20110009406 - Clements; Matthew J. ;   et al.
2011-01-13
Tetrahydrofuropyridones
App 20100331358 - Colandrea; Vincent J. ;   et al.
2010-12-30
Spiroindalones
App 20100137297 - Fletcher; Joan M. ;   et al.
2010-06-03
Novel 1.8-naphthyridine Compounds
App 20100056563 - Guiadeen; Deodialsingh ;   et al.
2010-03-04
Substituted Pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine Derivatives As Cannabinoid-1 Receptor Modulators
App 20100029697 - Debenham; John S. ;   et al.
2010-02-04
(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists
Grant 7,605,171 - Colandrea , et al. October 20, 2
2009-10-20
Substituted 4-Hydroxypyrimidine-5-Carboxamides
App 20090239876 - Clements; Matthew J. ;   et al.
2009-09-24
Edg receptor agonists
Grant 7,479,504 - Bugianesi , et al. January 20, 2
2009-01-20
Substituted furo[2,3-B] pyridine derivatives as cannabinoid-1 receptor modulators
App 20080269279 - Clements; Matthew J. ;   et al.
2008-10-30
(3,4-Disubstituted)Propanoic Carboxylates as Sip (Edg) Receptor Agonists
App 20080249093 - Colandrea; Vincent J. ;   et al.
2008-10-09
Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
App 20080207666 - Debenham; John S. ;   et al.
2008-08-28
N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
Grant 7,351,725 - Doherty , et al. April 1, 2
2008-04-01
Aminoalkylphosphonates and related compounds as Edg receptor agonists
Grant 7,309,721 - Budhu , et al. December 18, 2
2007-12-18
Aminoalkylphosphonates and related compounds as Edg receptor agonists
App 20070224263 - Doherty; George A. ;   et al.
2007-09-27
Heterocycle-substituted 3-alkyl azetidine derivatives
App 20070123505 - Baker; Robert K. ;   et al.
2007-05-31
1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
Grant 7,220,734 - Doherty , et al. May 22, 2
2007-05-22
1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
Grant 7,199,142 - Chen , et al. April 3, 2
2007-04-03
3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
App 20070043014 - Doherty; George A. ;   et al.
2007-02-22
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
App 20060252741 - Colandrea; Vincent J. ;   et al.
2006-11-09
Pyrrolidine modulators of CCR5 chemokine receptor activity
Grant 7,125,887 - Hale , et al. October 24, 2
2006-10-24
1-(Amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
App 20060161005 - Doherty; George A. ;   et al.
2006-07-20
1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
App 20050245575 - Chen, Weirong ;   et al.
2005-11-03
Aminoalkylphosphonates and related compounds as edg receptor agonists
App 20050107345 - Doherty, George A ;   et al.
2005-05-19
Selective s1p1/edg1 receptor agonists
App 20050070506 - Doherty, George A. ;   et al.
2005-03-31
Edg receptor agonists
App 20050033055 - Bugianesi, Robert L. ;   et al.
2005-02-10
N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
App 20050020837 - Doherty, George A. ;   et al.
2005-01-27
Pyrrolidine modulators of ccr5 chemokine receptor activity
App 20040087552 - Hale, Jeffrey J ;   et al.
2004-05-06
Selective S1P1/Edg1 receptor agonists
App 20040058894 - Doherty, George A. ;   et al.
2004-03-25
Morpholine and thiomorpholine tachykinin receptor antagonists
Grant 6,638,930 - Dorn , et al. October 28, 2
2003-10-28
Pyrrolidine modulators of CCR5 chemokine receptor activity
App 20020094989 - Hale, Jeffrey J. ;   et al.
2002-07-18
Morpholine and thiomorpholine tachykinin receptor antagonists
App 20020002164 - Dorn, Conrad P. ;   et al.
2002-01-03
Pyrrolidine and piperidine modulators of chemokine receptor activity
Grant 6,166,037 - Budhu , et al. December 26, 2
2000-12-26
Morpholine and thiomorpholine tachykinin receptor antagonists
Grant 5,872,116 - Dorn , et al. February 16, 1
1999-02-16
Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
Grant 5,780,467 - Dorn , et al. July 14, 1
1998-07-14
Morpholine and thiomorpholine tachykinin receptor antagonists
Grant 5,719,147 - Dorn , et al. February 17, 1
1998-02-17
Morpholine compounds are prodrugs useful as tachykinin receptor antagonists
Grant 5,691,336 - Dorn , et al. November 25, 1
1997-11-25
Process for preparing morpholine tachykinin receptor antagonists
Grant 5,637,699 - Dorn , et al. June 10, 1
1997-06-10
Substituted azetidinones as anti-inflammatory and antidegenerative agents
Grant 5,591,737 - Doherty , et al. January 7, 1
1997-01-07
Treatment of emesis with morpholine tachykinin receptor antagonists
Grant 5,512,570 - Dorn , et al. April 30, 1
1996-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed